PMDA drug package insert
パオスクレー内痔核内注射用250mg
PMDA Prescription drug · 鳥居薬品株式会社 · package insert Jun 6, 2023
Key facts
| Brand names | パオスクレー内痔核内注射用250mg |
|---|---|
| Nonproprietary names | フェノール |
| Companies | 製造販売元／鳥居薬品株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 内痔核硬化療法剤 |
| Therapeutic category codes | 872559 |
| YJ codes | 2559400A1033 |
| Approval numbers | 21900AMX00072000 |
| Package insert edition | 第1版 |
| Package insert date | Jun 6, 2023 |
| PMDA document key | 480306_2559400A1033_1 |
| PMDA company code | 480306 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: